https://www.nxtpsychedelics.com/news/articles/psychedelics/psyence-groups-nasdaq-listed-associate-psyence-biomedical-partners-with-fluence-and-ingenu-cro-to-train-research-therapists-for-phase-iib-psilocybin-trial/